1. 111PTAS-102 followed by regorafenib or the reverse sequence in advanced colorectal cancer. (25th November 2018) Authors: Nakatani, Y; Ueda, S; Tsuboguchi, Y; Yoshii, Y; Akiyoshi, K; Tsuya, A; Okazaki, S; Tokunaga, S; Daga, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1501TiPAfatinib (AFA) plus bevacizumab (BEV) combination after osimertinib (OSIME) failure for aDvanced EGFR-mutant non-small cell lung cancer (NSCLC): A multicenter prospective single arm phase II study (ABCD-study). (23rd October 2018) Authors: Hata, A; Katakami, N; Nishino, K; Mori, M; Yokoyama, T; Kurata, T; Tachihara, M; Takase, N; Daga, H; Kijima, T; Morita, S; Sakai, K; Nishio, K; Satouchi, M; Negoro, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 468PHistological type analysis of 10-year follow-up of WJTOG0105: A phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer. (24th November 2019) Authors: Tsuboi, M; Zenke, Y; Chiba, Y; Satouchi, M; Mitsuoka, S; Shimizu, J; Daga, H; Fujimoto, D; Mori, M; Aoki, T; Sawa, T; Omori, S; Saka, H; Iwamoto, Y; Okuno, M; Hirashima, T; Kashiwabara, K; Tachihara, M; Yamamoto, N; Nakagawa, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-079Efficacy and safety of nivolumab monotherapy for metastatic gastric cancer. (20th June 2018) Authors: Akiyoshi, K; Tsuboguchi, Y; Ueda, S; Okazaki, S; Tsuya, A; Tokunaga, S; Daga, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗